Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4821867

Cc1cc(CCS(C)(=O)=O)ccc1N.N

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.56
PTGS2 P35354 1/20 0.49
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 1/20 0.41
RECQL P46063 1/20 0.38
S100B P04271 1/20 0.37
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15292050 0.81 SKP2 (0.51) SKP2PTGS2ALDH1A1CYP3A4TDP1
SCHEMBL31634603 0.80 SKP2 (0.73) SKP2PTGS2ALDH1A1CYP3A4TDP1
SCHEMBL841783 0.80 SKP2 (0.73) SKP2PTGS2ALDH1A1CYP3A4TDP1
SCHEMBL1654641 0.79 SKP2 (0.52) SKP2ALDH1A1CYP3A4TDP1TSHR
SCHEMBL3482834 0.78 SKP2 (0.70) SKP2PTGS2ALDH1A1CYP3A4TDP1
Ammonia Solution, Strong SCHEMBL5929377 0.77 SKP2 (0.63) SKP2ALDH1A1CYP3A4TDP1TSHR
SCHEMBL28853899 0.77 TSHR (0.51) PTGS2ALDH1A1CYP3A4TDP1TSHR
SCHEMBL11747082 0.77 SKP2 (0.50) SKP2PTGS2ALDH1A1CYP3A4TDP1
SCHEMBL3514830 0.77 SKP2 (0.81) SKP2ALDH1A1CYP3A4TDP1TSHR
SCHEMBL11690780 0.76 PTGS2 (0.55) PTGS2ALDH1A1TSHRRECQLCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'OREAL S.A. (FR) 2006-01-12 US claimed
EP-1568687-A1 Sulphur-containing secondary para-Phenylenediamines, dying composition containing such para-phenylenediamines and methods using this composition and use L'OREAL (FR) 2005-08-31 EP claimed
US-7347879-B2 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'Oreál, S.A. (FR) 2008-03-25 US disclosed
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'OREAL S.A. (FR) 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof KRT18, CDC73, DSG1 SKP2 1023/4885PTGS2 3816/4885ALDH1A1 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.